Current Controversies in the Management of the Anemia of Prematurity

Seminars in Perinatology

Volumn 33, Issue 1, 2009, Pages 29-34

  Bishara, Nader ^a   Ohls, Robin K ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

anemia; erythropoietin; oxygen delivery; prematurity; transfusion

Indexed keywords

ALPHA TOCOPHEROL; CYANOCOBALAMIN; FOLIC ACID; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ERYTHROCYTE TRANSFUSION; HUMAN; NEUROPROTECTION; NEWBORN INTENSIVE CARE; PHLEBOTOMY; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; REVIEW;

ANEMIA, NEONATAL; BLOOD TRANSFUSION; ERYTHROPOIETIN; HEMATOCRIT; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES;

EID: 58249128175     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2008.10.006     Document Type: Review

References (45)

1. Bifano E., and Curran T. Minimizing donor blood exposure in the neonatal intensive care unit. Current trends and future prospects. Clin Perinatol 22 (1995) 657-669
2. Ohls R., Ehrenkranz R., Das A., et al. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 114 (2004) 1287-1291
3. Donato H., Vain N., Rendo P., et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: Results of a randomized, placebo-controlled, multicenter trial. Pediatrics 105 (2000) 1066-1072
4. Maier R., Obladen M., Müller-Hansen I., et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 141 (2002) 8-15
5. Ohls R. Why, when and how should we provide red cell transfusions to neonates?. In: Ohls R., and Yoder M.C. (Eds). Hematology, Immunology and Infectious Disease (2008), Elsevier, Philadelphia, PA 44-57
6. Napolitano L., and Corwin H. Efficacy of red blood cell transfusion in the critically ill. Crit Care Clin 20 (2004) 255-268
7. Chant C., Wilson G., and Friedrich J. Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: A cohort study. Crit Care 10 (2006) R140
8. Croce M., Tolley E., Claridge J., et al. Transfusions result in pulmonary morbidity and death after a moderate degree of injury. J Trauma 59 (2005) 19-23 discussion 23-24
9. Malone D., Dunne J., Tracy J., et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54 (2003) 898-905 discussion 905-907
10. Hébert P., Wells G., Blajchman M., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340 (1999) 409-417
11. Lacroix J., Hébert P., Hutchison J., et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 356 (2007) 1609-1619
12. Shannon K., Keith J.R., Mentzer W., et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 95 (1995) 1-8
13. Widness J., Seward V., Kromer I., et al. Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr 129 (1996) 680-687
14. Maier R., Sonntag J., Walka M., et al. Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g. J Pediatr 136 (2000) 220-224
15. Bifano E. The effect of hematocrit (HCT) level on clinical outcomes in extremely low birthweight (ELBW) infants. Pediatr Res 49 (2001) 311A
16. Bifano E., Bode M.M., and D'Eugenio D.B. Prospective randomized trial of high vs. low hematocrit in Extremely Low Birth Weight (ELBW) infants: One year growth and neurodevelopmental outcome. Pediatr Res 51 (2002) 325A
17. Bell E., Strauss R., Widness J., et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 115 (2005) 1685-1691
18. Boedy R., and Mathew O. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 116 (2005) 1048-1049 author reply 1049-1050
19. Murray N., Roberts I., and Stanworth S. Red blood cell transfusion in neonates. Pediatrics 116 (2005) 1609 author reply 1609-1610
20. Swamy R., and Embleton N. Red blood cell transfusions in preterm infants: Is there a difference between restrictive and liberal criteria?. Pediatrics 117 (2006) 257-258 author reply 258-259
21. Kirpalani H., Whyte R., Andersen C., et al. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 149 (2006) 301-307
22. Alverson D. The physiologic impact of anemia in the neonate. Clin Perinatol 22 (1995) 609-625
23. Wardle S., Garr R., Yoxall C., et al. A pilot randomised controlled trial of peripheral fractional oxygen extraction to guide blood transfusions in preterm infants. Arch Dis Child Fetal Neonatal Ed 86 (2002) F22-F27
24. Bifano E., Smith F., and Borer J. Relationship between determinants of oxygen delivery and respiratory abnormalities in preterm infants with anemia. J Pediatr 120 (1992) 292-296
25. Izraeli S., Ben-Sira L., Harell D., et al. Lactic acid as a predictor for erythrocyte transfusion in healthy preterm infants with anemia of prematurity. J Pediatr 122 (1993) 629-631
26. Bard H., Fouron J., Chessex P., et al. Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity in infants with bronchopulmonary dysplasia. J Pediatr 132 (1998) 630-634
27. Böhler T., Janecke A., and Linderkamp O. Blood transfusion in late anemia of prematurity: effect on oxygen consumption, heart rate, and weight gain in otherwise healthy infants. Infusionsther Transfusionsmed 21 (1994) 376-379
28. Alkalay A., Galvis S., Ferry D., et al. Hemodynamic changes in anemic premature infants: Are we allowing the hematocrits to fall too low?. Pediatrics 112 (2003) 838-845
29. Madan A., Kumar R., Adams M., et al. Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants. J Perinatol 25 (2005) 21-25
30. Widness J., Madan A., Grindeanu L., et al. Reduction in red blood cell transfusions among preterm infants: Results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics 115 (2005) 1299-1306
31. Lin J., Strauss R., Kulhavy J., et al. Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics 106 (2000) E19
32. Maier R., Obladen M., Kattner E., et al. High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group. J Pediatr 132 (1998) 866-870
33. Ohls R.K. Developmental erythropoiesis. In: Polin R., and Fox W. (Eds). Fetal and Neonatal Physiology. (ed 4) (2008), Elsevier, Philadelphia, PA (in press)
34. Haiden N., Schwindt J., Cardona F., et al. Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants. Pediatrics 118 (2006) 2004-2013
35. Warwood T., Ohls R., Lambert D., et al. Intravenous administration of darbepoetin to NICU patients. J Perinatol 26 (2006) 296-300
36. Warwood T.L., Ohls R.K., Wiedmeier S.E., et al. Single-dose darbepoetin administration to anemic preterm neonates. J Perinatol 25 (2005) 725-730
37. Lerner G., Kale A., Warady B., et al. Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease. Pediatr Nephrol 17 (2002) 933-937
38. De Palo T., Giordano M., Palumbo F., et al. Clinical experience with darbepoietin alfa (NESP) in children undergoing hemodialysis. Pediatr Nephrol 19 (2004) 337-340
39. Roohi M, Connie Peceny M, Ohls R: A randomized, masked, dose response study of darbepoetin administered to preterm infants. Poster presented at the Pediatric Academic Society Meeting. Toronto, 2007A
40. Topf J.M. CERA: Third-generation erythropoiesis-stimulating agent. Exp Opin Pharmacother 9 (2008) 839-849
41. Patel S., Rowe M., Winters S., et al. Elevated erythropoietin mRNA and protein concentrations in the developing human eye. Pediatr Res 63 (2008) 394-397
42. Romagnoli C., Zecca E., Gallini F., et al. Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?. Eur J Pediatr 159 (2000) 627-628
43. Sola A., Wen T.C., Hamrick S.E., et al. Potential for protection and repair following injury to the developing brain: A role for erythropoietin?. Pediatr Res 57 (2005) 110R-117R
44. Juul S.E., McPherson R.J., Bauer L.A., et al. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: Pharmacokinetics and safety. Pediatrics 122 (2008) 383-391
45. Bierer R., Peceny M., Hartenberger C., et al. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 118 (2006) e635-e640